Welcome to our dedicated page for Healthpeak Properties SEC filings (Ticker: DOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthpeak Properties, Inc. filings document the regulatory record of a Maryland REIT focused on healthcare discovery and delivery real estate. Form 8-K reports furnish quarterly and annual financial results, supplemental operating information, Regulation FD materials, non-GAAP reconciliations, and material agreements tied to credit facilities and other financing activity.
Proxy and annual-meeting filings describe board elections, shareholder voting results, executive compensation, and governance matters. The filing record also covers capital-structure disclosures for Healthpeak and Healthpeak OP, including unsecured term loan amendments, delayed-draw financing, senior notes, and related subsidiary financing activity.
Griffin R Kent Jr reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Griffin R Kent Jr received a grant of 9,744 shares of Common Stock on May 6, 2026 as a stock-based award with no cash purchase price. Following this grant, he directly holds 90,195 shares.
The award consists of restricted stock units that vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders, tying compensation to continued board service and future company performance.
Weiss Richard A. reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Richard A. Weiss received an award of 9,744 shares of common stock in the form of restricted stock units. These units were granted at no cash cost as equity compensation and increase his direct holdings to 79,469 shares of common stock.
The restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders, aligning director incentives with shareholder interests over this period.
Lias-Booker Ava reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Ava Lias-Booker received an equity grant of 9,744 shares of Common Stock as a compensation award. Following this grant, she directly holds 45,305 shares. The award consists of restricted stock units that vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company’s next annual meeting of stockholders.
Lewis Sara Grootwassink reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Sara Grootwassink Lewis reported an equity compensation grant. She received 9,744 shares of Common Stock as a grant or award on May 6, 2026, bringing her directly held shares to 56,488.
The award represents restricted stock units that vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders. She also reports indirect holdings of 9,000 shares in an IRA and 22,000 shares held through a trust.
HEALTHPEAK PROPERTIES, INC. director James B. Connor reported an equity compensation grant of 9,744 shares of Common Stock, recorded as a grant or award acquisition at $0.0000 per share. After this grant, he directly owns 38,169 shares of common stock and indirectly holds 10 shares through a spouse's trust.
The 9,744-share award is in the form of restricted stock units that vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders, making this a routine, time-based director compensation grant rather than an open-market purchase or sale.
Cartwright Brian G. reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Brian G. Cartwright received an award of 9,744 shares of Common Stock on May 6, 2026 at no cash cost, bringing his direct holdings to 83,490 shares. The related restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders.
Sandstrom Katherine M reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Katherine M. Sandstrom received an equity award of 9,744 shares of Common Stock on May 6, 2026, recorded at a price of $0.00 per share as a grant rather than an open-market trade. According to the footnote, these restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders. Following this award, Sandstrom directly holds a total of 76,669 shares of the company's stock.
Healthpeak Properties, Inc. reported solid first‑quarter 2026 growth while reshaping its portfolio. Total revenue reached $752.9 million, up from $702.9 million a year earlier, driven by outpatient medical, lab, and senior housing properties. Net income rose to $199.7 million from $50.1 million, and diluted EPS increased to $0.28 from $0.06.
The company completed the Janus Living, Inc. IPO, issuing 48.3 million Class A‑1 shares to public investors for $966 million in gross proceeds, leaving Healthpeak with 81.6% voting and economic rights and $560.4 million of noncontrolling interest. Healthpeak also bought out a JV partner’s 46.5% stake in the SWF Senior Housing JV for $312 million and acquired additional senior housing portfolios in Georgia, Florida, and Washington plus lab land in Massachusetts.
Operating cash flow was $260.9 million, while the company deployed $638.6 million on investing activities, largely for acquisitions and development. Cash and cash equivalents rose to $1.17 billion, supported by active use of a $2.0 billion commercial paper program and $1.25 billion of term loans alongside $6.9 billion of senior unsecured notes.
Healthpeak Properties, Inc. reported strong first quarter 2026 results and raised its full-year earnings outlook. Net income applicable to common shares rose to $193.5 million, or $0.28 per share, on total revenues of $753 million. Diluted Nareit FFO was $0.42 per share and diluted FFO as Adjusted was $0.45 per share.
The quarter was driven by the successful IPO of Janus Living, which generated approximately $880 million of net proceeds and is 81.6% owned by Healthpeak. Healthpeak contributed $714 million of senior housing acquisitions to Janus and Janus reported first quarter FFO as Adjusted of $0.23 per share with revenue and Adjusted EBITDAre up 35% and 42% year over year.
Healthpeak executed $267 million of recapitalizations, dispositions, and loan repayments, including selling an 80% interest in a six-property outpatient medical portfolio to Blackstone for about $170 million, and repurchased 5.9 million shares for roughly $100 million. Net Debt to Adjusted EBITDAre was 5.4x. The company declared second quarter common dividends totaling $0.305 per share and updated 2026 guidance, lifting diluted EPS to $0.46–$0.50 and FFO as Adjusted per share to $1.71–$1.75.
Healthpeak Properties, Inc. held its annual stockholder meeting on April 30, 2026, with 632,249,628 common shares represented, about 91% of shares entitled to vote, establishing a quorum. All director nominees were elected with strong support, generally between 96.4% and 99.8% of votes cast, and the Board size was set at nine members.
Stockholders approved the advisory vote on 2025 executive compensation, with 522,635,664 votes in favor and 89.2% of votes cast supporting the proposal. They also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 97.2% of votes cast in favor.